---
figid: PMC9138592__biomedicines-10-01146-g001
pmcid: PMC9138592
image_filename: biomedicines-10-01146-g001.jpg
figure_link: /pmc/articles/PMC9138592/figure/biomedicines-10-01146-f001/
number: Figure 1
figure_title: ''
caption: Metabolic reprogramming in cancer involves glucose and cholesterol metabolism
  alterations. The energy production from fats has the same weight as alterations
  in glucose metabolism in supporting the viability of cancer cells.
article_title: Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia
  Cells by Bisphosphonate Drugs .
citation: Emanuela Chiarella, et al. Biomedicines. 2022 May;10(5):1146.
year: '2022'

doi: 10.3390/biomedicines10051146
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI

keywords:
- mevalonate pathway
- AML
- bisphosphonates
- small GTPases
- protein isoprenylation

---
